| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9888183 | Clinica Chimica Acta | 2005 | 6 Pages |
Abstract
Autoantibodies, and the antigens they recognise, are potentially valuable in the prediction and prevention respectively of type 1 diabetes as well as in the classification of autoimmune diabetes. Screening the general population for type 1 diabetes susceptibility is now feasible. Trials to prevent type 1 diabetes using disease-associated autoantigens are now in progress.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
K.D. Schmidt, C. Valeri, R.D.G. Leslie,